Live Breaking News & Updates on Translational Neural Prosthetics

Stay updated with breaking news from Translational neural prosthetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ultivue, Inc.: Ultivue Announces AI Partner Ecosystem to Accelerate Analysis of Multiplex Immunofluorescence Image Data in Translational Medicine

Ultivue, Inc., an industry leader in multiplexing assays and analytics solutions for tissue biomarker studies, announced today multiple collaborations for AI-powered spatial phenomics solutions for translational ....

Kostenloser Wertpapierhandel , Florian Leiss , Ultivue Inc , Image Data Services , Digital Health Strategies , Vp Digital Health Strategies , Indica Labs , Keen Eye , Health Strategies , President Digital Health Strategies ,

Oncolytics Biotech Inc.: Oncolytics Biotech Announces Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors in Science Translational Medicine

- Pelareorep-CAR T combination may expand the commercial potential of CAR T cells to solid tumors - Combining CAR T cells with pelareorep prevented antigen escape by creating CAR T cells ....

Matt Coffey , Jon Patton , Timothy Mccarthy , Thomas Heineman , Oncolytics Biotech Inc , National Cancer Institute , Company Contact , Securities Exchange , Global Head Of Business Development , Duke University , Science Translational Medicine , Mayo Clinic , Chief Medical Officer , Oncolytics Biotech , Global Head , Business Development , Chief Executive Officer , Translational Medicine , Engineering Patient Immune Cells , Treat Their , Updated July , Securities Exchange Act ,

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS(R) PLATFORM

DJ QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS(R) PLATFORM Quotient Sciences QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL ....

United Kingdom , Mark Egerton , Peter Scholes , Abdul Khalifeh , Facto Communications , Study Of Drug Development , Quotient Sciences Translational Pharmaceutics , Tufts Center , News Service , Quotient Sciences , Translational Pharmaceutics , Sciences Translational Pharmaceutics , Drug Development , Dow Jones Newswires ,

LUMICKS: New study published in Translational Medicine highlights cell avidity's power as a functional biomarker for improved CAR-T design in preventing tumor escape

AMSTERDAM, Jan. 25, 2022 /PRNewswire/ LUMICKS, a next generation life science tools company, today announced that research findings from a consortium, led by researchers at Cancer Center ....

Noord Holland , Kostenloser Wertpapierhandel , Joshua Young , Maria Themeli , Andrea Candelli , Kassandra Barbetsea , Amsterdam University Medical Centers , Cancer Center Amsterdam , Science Translational Medicine , Avidity Analyzer , Science Translational , Movi Analyzer , Chief Scientific Officer , Dynamic Single Molecule , Cell Avidity , Label Free Microscopy ,

ReproCELL Incorporated : How we established an in vitro Parkinson's Disease model

From patient screening to tissue collection, primary culture derivation, iPSC generation, and even co-culture. Read on to find out how they successfully developed this translational assay for drug. | November 24, 2021 ....

Krickset Al , Gen Reprogramming Technology , Neural Differentiation Services , Obtaining Primary Tissues , Gen Reprogramming , Reprocell Incorporated Stock Exchange , Press Release , Or 4978 Jp3974770004 ,